- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 Positive Advanced Solid Tumors in Australia
Total 485 results
-
Hutchison Medipharma LimitedTerminated
-
AbbVieRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Israel, Japan, Australia, Spain, Germany
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingMTAP-deleted Solid TumorsAustralia, United States
-
Imugene LimitedRecruitingSolid Tumor | Metastatic Cancer | Cholangiocarcinoma | Bile Duct Cancer | Advanced Solid Tumor | Solid Tumor, Adult | Solid CarcinomaUnited States, Australia
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Belgium, Denmark, Canada, Australia
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
AbbVieActive, not recruitingAdvanced Solid TumorsUnited States, Australia, Canada, Israel, Japan, Korea, Republic of, Netherlands, Puerto Rico, Spain, Taiwan
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
Activartis BiotechCompletedChildhood Solid TumorAustria
-
AmgenRecruitingAdvanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C MutationUnited States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
Binacea Pharma, Inc.RecruitingRefractory Solid TumorsAustralia
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Medical University of ViennaUnknown
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, United Kingdom, Taiwan, Australia
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, Taiwan, Australia
-
GlaxoSmithKlineNot yet recruitingSolid TumorsUnited States, Canada, Australia
-
EpimAb Biotherapeutics (Suzhou)Co., Ltd.RecruitingAdvanced/Metastatic Solid Tumors | Relapse/Refractory LymphomaChina, Australia
-
Curis, Inc.CompletedSolid TumorUnited States, Australia
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
ModernaTX, Inc.Merck Sharp & Dohme LLCRecruitingSolid TumorsUnited States, Australia
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Turkey, United Kingdom, Switzerland, Italy
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Genentech, Inc.Active, not recruitingSolid TumorsUnited States, Italy, Korea, Republic of, Spain, Denmark, Taiwan, Australia, France, Netherlands, United Kingdom, Singapore, Belgium, Japan, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
AbbVieCompletedAdvanced Solid TumorsUnited States, Australia, Austria, Belgium, Canada, Finland, France, Japan, Spain, Taiwan
-
Medical University InnsbruckCelgene Corporation; Innsbruck - Tyrolean Working Group of Experimental Oncology...Unknown
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, China, Belgium, Australia, Italy, Korea, Republic of, Germany, Netherlands, Poland, Romania, Thailand
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, Australia, France, Taiwan
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
InventisBio Co., LtdMerck Sharp & Dohme LLCActive, not recruitingNSCLC | Solid Tumor, Adult | CRCUnited States, Taiwan, Australia, Korea, Republic of
-
AbbVieTerminatedAdvanced Solid Tumors CancerUnited States, Australia, Denmark, Spain
-
St Vincent's Hospital, SydneyTerminatedSolid Tumor | Androgen Receptor Gene OverexpressionAustralia
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingSolid TumorSpain, Australia, Belgium, United States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | NeuroblastomaUnited States, Australia
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
PfizerCompletedSolid TumorsUnited States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
-
Presage BiosciencesTakedaWithdrawn